Intellia Therapeutics Inc.

Stock Earnings

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Intellia Therapeutics

Analysts Viewpoint

In a filing, Intellia Therapeutics Inc revealed its Director Bhanji Muna unloaded Company’s shares for reported $2642.0 on Jan 29

Insiders Updates

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

Intellia Therapeutics Inc’s recently made public that its VP, Chief Accounting Officer Dube Michael P unloaded Company’s shares for reported

Insiders Updates

Intellia Therapeutics Inc’s recently made public that its VP, Chief Accounting Officer Dube Michael P unloaded Company’s shares for reported

Analysts Viewpoint

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Intellia Therapeutics

Stock Earnings

Intellia Therapeutics Inc’s filing revealed that its VP, Chief Accounting Officer Dube Michael P unloaded Company’s shares for reported $16711.0

Stock Earnings

Intellia Therapeutics Inc’s filing revealed that its VP, Chief Accounting Officer Dube Michael P unloaded Company’s shares for reported $16711.0

Tag: Intellia Therapeutics Inc.